Research study Program year 2020 Source: CMS Open Payments

1009742

ClinicalTrials.gov NCT03439254

Research payments

$28,007,683

3,955 payments

Through program year 2020, $28,007,683 in research payments was reported against 1009742, across 3,955 payments, paid by Intercept Pharmaceuticals, Inc..

Paid by: Intercept Pharmaceuticals, Inc.
ClinicalTrials.gov: NCT03439254

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$11,210,262	2,172
2019	Research	$16,797,421	1,783

Breakdown

Who paid Research payments · program years 2019–2020

Intercept Pharmaceuticals, Inc. $28,007,683 3,955 payments

Who received the money Research payments · program years 2019–2020

Institute For Liver Health Organisation paid for research $1,429,315 98 payments
Clinical Trial Source LLC Organisation paid for research $926,322 108 payments
Bon Secours Richmond Community Hospital Organisation paid for research $768,492 48 payments
Diabetes And Endocrinology Consultants Pc Organisation paid for research $756,976 33 payments
Objective Gi LLC Organisation paid for research $741,454 112 payments
American Research Corporation Organisation paid for research $699,610 33 payments
Tandem Clinical Research LLC Organisation paid for research $616,925 34 payments
Duke University Organisation paid for research $604,859 22 payments
Medycal Research Inc Organisation paid for research $582,044 26 payments
Tx Digestive Disease Consultants Organisation paid for research $456,109 66 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.